Some flu vaccines promise a little more protection

by Lauran Neergaard

It's time to get your flu vaccine, and this fall some brands promise a little extra protection.

For the first time, certain vaccines will guard against four strains of flu rather than the usual three.

They're called quadrivalent vaccines, and they're so new that they'll make up only a fraction of the year's supply.

All the sold in the U.S. this year will be the four-strain kind, and a few varieties of shots.

Specialists say that's just one of many flu options to choose from, not necessarily a better one.

The government recommends a yearly for nearly everyone, starting at 6 months of age.

Early fall is the ideal time, so protection kicks in before flu starts spreading.

not rated yet
add to favorites email to friend print save as pdf

Related Stories

FDA approves first 4-in-1 flu vaccine

Feb 29, 2012

Federal health officials have approved the first vaccine that protects against four strains of the common flu, offering one additional layer of protection against the influenza virus that affects millions each year.

Recommended for you

Determine patient preferences by means of conjoint analysis

Jul 29, 2014

The Conjoint Analysis (CA) method is in principle suitable to find out which preferences patients have regarding treatment goals. However, to widely use it in health economic evaluations, some (primarily methodological) issues ...

FDA approves hard-to-abuse narcotic painkiller

Jul 25, 2014

(HealthDay)—A new formulation of a powerful narcotic painkiller that discourages potential abusers from snorting or injecting the drug has been approved by the U.S. Food and Drug Administration.

Race affects opioid selection for cancer pain

Jul 25, 2014

(HealthDay)—Racial disparities exist in the type of opioid prescribed for cancer pain, according to a study published online July 21 in the Journal of Clinical Oncology.

FDA approves tough-to-abuse formulation of oxycodone

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe ...

User comments